Water Street targets generic injectables sector with CMO buy
Water Street Healthcare Partners has bought US generic injectables contractor Custopharm.
Archives for February 5, 2015
Dispatches from InformEx
Post-IPO Catalent turns to internal investments to meet new demands
With its stock up about 35% since its IPO, Catalent is continuing to invest internally to meet the growing demands of its clients.
UPDATE-2
US FDA Commissioner Margaret Hamburg to retire after six years
Margaret Hamburg will retire from her role as Commissioner of the US FDA after nearly six years.
Exclusive interview
It's not the size... CRO Simbec-Orion on why it can compete with Quintiles
Being a drug developer not just a service provider differentiates Simbec-Orion from the Big CROs according to CEO Ronald Openshaw, whose firm signed two strategic partnerships last week.